Quantum Leap: Is pharma ready for the next computing revolution?
Partha Anbil, SVP, Life Sciences, at Coforge Limited, and Alex Kandybin, Founder of Quantum Wargaming, explore how quantum computing is… Read More
Partha Anbil, SVP, Life Sciences, at Coforge Limited, and Alex Kandybin, Founder of Quantum Wargaming, explore how quantum computing is… Read More
With topics as diverse as quantum computing, ion channel drug discovery and antisense oligonucleotides, these were DDW readers’ most-read articles of 2025. 10. We need international partnerships to get new cancer drugs into the clinic On International Clinical Trials Day, Lars Erwig, Director of the… Read More
Quantum company IonQ has partnered with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate next-generation therapeutics using hybrid quantum and quantum-AI technologies. The collaboration will initially focus on areas including bioprocess optimisation, disease-modelling workflows, and quantum-enhanced simulation to support the design and manufacturing of advanced therapies. By… Read More
Adityo Prakash, CEO of Verseon, introduces a new mathematical approach to computing molecular interactions. The objective of small-molecule drug discovery is to find binders to target proteins involved in disease processes. However, the discovery and development of novel small-molecule therapeutics remains one of the most resource-intensive endeavors… Read More
DDW Editor Reece Armstrong takes a look at some of the recent activity in cancer research and examines where the biggest opportunities are in oncology. In January this year, researchers from the University of Toronto (UoT) and Insilico Medicine published a paper detailing how quantum computing combined with generative… Read More
Saurabh Singal, Founder of Molecule AI, examines the impact that quantum computing can, and will have, on drug discovery and development. A quantum leap in pharma In 2019, Google announced that its quantum computer had achieved a groundbreaking milestone1 – solving a problem in 200 seconds that would take the… Read More
A study co-led by University of Toronto (U of T) researchers and Insilico Medicine has demonstrated the potential of quantum computing and artificial intelligence (AI) to transform the drug discovery pipeline. “It’s an exciting time to be working at the interface of chemistry, quantum computing and AI. Read More
A team of researchers from the University of Nottingham have received funding to explore the capabilities of quantum computing for developing new drugs for myotonic dystrophy. Building on an initial award of over £1 ($1.3) million, a team of researchers from the University of Nottingham, with… Read More
French start-ups Pasqal and Qubit Pharmaceuticals are among the 12 selected performers for the Quantum for Bio programme in consortium with the Unitary Fund. Together with the Unitary Fund, Pasqal and Qubit will receive $4.5 million of the total $40 million awarded through the various milestones… Read More
Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, has raised £1.8M in seed funding, which will facilitate further validation of Kuano’s quantum simulation platform for the design of more effective drug candidates targeting enzymes, as well as continued company growth… Read More
In a new scientific paper, AI-driven biotech Gero has demonstrated the feasibility of applying quantum computing to drug design and generative chemistry. The research, published in Scientific Reports, outlines how a hybrid quantum-classical machine-learning model was used to interface between classical and quantum computational devices with… Read More
BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating life science research, has launched a new deep tech accelerator start-up programme, the Deep Tech Lab – Quantum, to propel emergent and disruptive quantum science and biotechnology solutions toward the marketplace. Deep tech and quantum science have… Read More
This is the latest episode of the free DDW podcast, “Complex problems require complex solutions”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “How quantum computing can benefit drug discovery” and “Sitting down with Dr Michael Hayden from… Read More
Algorithmiq, a Helsinki-based quantum computing start-up, has entered into an engagement with IBM to progress in its exploration of quantum algorithms that attempt to solve complex issues in life sciences. Between IBM’s hardware, software and quantum applications expertise and Algorithmiq’s algorithm developers, the companies hope to explore… Read More
Listen to this article on the DDW Podcast: Brad Loren, Matthew Marrone, and Christopher Singer, of intellectual property and technology law firm McAndrews, Held & Malloy, on quantum computing and its benefits to drug discovery. Explaining quantum computing and its promise Before we… Read More